Search Results

You searched for : TReatmentofcancer

	Sun Pharma Announces Settlement of Patent Litigation for Generic Revlimid (lenalidomide) in US The license will also allow Sun Pharma to manufacture and sell an unlimited quantity of generic lenalidomide capsules in the US beginning January 31, 2026.... Jun 22
	EMERCell signs strategic partnership with Onward Therapeutics EMERCell signs strategic partnership with Onward Therapeutics for the development of its NK cell therapy technology ... Feb 18
	Molecular Templates establishes multi-target collaboration with Bristol Myers Squibb Molecular Templates collaborates with Bristol Myers Squibb for the discovery and development of next generation engineered toxin bodies ... Feb 17
	Bristol Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed Methylated Glioblastoma Multiforme ... Dec 23
	BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody CAN10 The majority of the work will be completed in 2021 to start clinical trials as early as possible during 2022... Nov 26
	National Cancer Awareness Day The Most Common Types of Cancer in India Include: Breast Cancer, Cervical Cancer and Oral Cancer.... Nov 07
	Gilead Sciences and Jounce Therapeutics announce exclusive license agreement for novel immunotherapy program Gilead Sciences, Inc. collaborates with Jounce Therapeutics, Inc., focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers... Sep 02
7 Matching result(s) found!

-Advertisements-